COVID-19 Associated Pulmonary Aspergillosis - The Other CAPA

Explore COVID-19 Associated Pulmonary Aspergillosis (CAPA) in this 46-minute video from the American Society for Microbiology. Learn about CAPA's prevalence among ICU patients with COVID-19, understand the unique challenges in identifying invasive aspergillosis in COVID-19 patients, and review recent publications discussing specific assays and diagnostic approaches for optimal detection. Featuring insights from Dr. Martin Hoenigl and Prof. Alexandre Alanio, this episode of Editors in Conversation covers the definition of CAPA, its similarities with influenza, the benefits of lateral flow assays, and the distinction between possible and proven CAPA. Gain valuable knowledge on serum sensitivity, diagnostic criteria, and key takeaways for managing this important complication of COVID-19.

Intro
Dr Martin Hohengil
Dr Aljandre Alonzo
What is COVID19
Use of corticosteroids
Similarities with influenza
Benefits of a lateral flow assay
Possible vs proven kappa
Lateral flow test
Serum sensitivity
Discussion
Takehome